India’s bio-economy can reach $ 300 bn, potentially doubling its growth from 2024
Indian Bio-Economy Report 2024 by the Association of Biotechnology Led Enterprises (ABLE) highlights India’s current bioeconomy,…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
COVID-19
We built the CoviRx database through BITS Pilani to help identify drugs that could be repurposed for…
Professor Seshadri Vasan, Honorary Professor of Medical and Health Sciences at Edith Cowan University (Australia) and University…
Indian Immunologicals hosts pandemic preparedness conclave in Hyderabad
The objective of this conclave was to ideate, explore and collaborate on the learnings of the pandemic, and to build a more robust…
Novavax reaches settlement with UK Health Security Agency over COVID-19 vaccine agreement
Novavax to refund $123.8 million to UKHSA in quarterly payments through 2027
IIL develops needle-free intranasal COVID-19 booster vaccine
New vaccine developed in collaboration with Griffith University published in ‘Nature Communications’
FDA approves and authorises updated mRNA COVID-19 vaccines
The mRNA COVID-19 vaccines have been updated with a monovalent component that corresponds to the Omicron variant KP.2 strain…
FDA awards record number of review designations to mRNA vaccines in 2023: GlobalData
Following FDA approval in August 2021, Pfizer’s Comirnaty became the first mRNA vaccine to enter the global market, followed by…
Moderna receives U.S. FDA approval for RSV vaccine mRESVIA(R)
mRESVIA is Moderna's second approved product and reportedly the only RSV vaccine available in single-dose pre-filled syringes
…
Regional variations uncovered in the impact of dexamethasone treatment for severe COVID-19: Study
This study was conducted in Europe and India to examine the effects of giving patients injectable 12 mg versus 6 mg of…
Affordability is tied to quality
In a freewheeling conversation, Leena Menghaney, Regional Head, MSF Access Campaign explains to Viveka Roychowdhury how the Covid…